Peritoneal metastases from colorectal carcinoma: Exploring the potential of immunotherapy as a treatment adjunct

20%的肠癌患者有涉及腹部衬里的疾病，称为腹膜。这些病人做得很差。大多数是不能手术的，化疗对这些患者的反应很差。因此，迫切需要探索新的治疗方法。刺激免疫细胞对抗癌症的新药在其他癌症中显示出希望。我们的目标是评估这种治疗在腹膜疾病中的潜力，目的是改善患者的预后。

Twenty percent of patients with bowel cancer have disease involving the lining of the abdomen, called the peritoneum. These patients do poorly. The majority are inoperable, and chemotherapy has poor response in these patients. Therefore, there is a dire need to explore new treatments. Newer drugs that stimulate the immune cells to fight cancer have shown promise in other cancers. We aim to assess the potential of this treatment in peritoneal disease, with the aim of improving patient outcomes.